by Eric L. Young | Feb 12, 2020 | CFTC, Fraud, Whistleblower
The Commodity Futures Trading Commission (“CFTC” or “Commission”) may not be as familiar as it’s more well known counterpart, the Securities and Exchange Commission, but the agency nonetheless serves an equally vital function by ensuring stability and confidence...
by Eric L. Young | Jan 6, 2020 | McEldrew Young - News & Alerts, Press Releases, Qui Tam, Settlements
Attorney Eric. L. Young announced today that Teva Pharmaceuticals USA, Inc., Teva Neuroscience, Inc., and Teva Sales and Marketing, Inc. (hereinafter collectively referred to as “TEVA”) have settled allegations in a qui tam complaint filed by McEldrew...
by Eric L. Young | Oct 17, 2019 | False Claims Act, Health Care, Medicare, Qui Tam, Settlements, Stark / AKS, Whistleblower
On October 2, 2019, Retina Institute of California Medical Group (RIC), along with its former CEO and several physicians, agreed to pay $6.65 million to resolve allegations of False Claims Act violations. RIC is a medical partnership of ophthalmologists with multiple...
by Eric L. Young | Aug 2, 2019 | Health Care, Kickbacks, Medicaid, Medicare, Qui Tam, Stark / AKS, Uncategorized, Whistleblower
In the first half of 2019, the United States Department of Justice (“DOJ”) has shown that it intends to aggressively pursue health care providers who engage in fraudulent schemes to enrich themselves at the expense of their patients and American taxpayers. The DOJ has...
by Eric L. Young | Jun 7, 2019 | False Claims Act, Fraud, Health Care, Qui Tam, Whistleblower
INSYS Agrees to Global Resolution of Claims Arising from Separate DOJ Criminal and Civil Investigations The Department of Justice announced that INSYS Therapeutics, Inc. (“INSYS”) has agreed to pay $225 million to resolve allegations that it paid kickbacks and engaged...
